Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma

被引:62
作者
Lonardo, F
Li, XH
Siddiq, F
Singh, R
At-Abbadi, M
Pass, HI
Sheng, SJ
机构
[1] Wayne State Univ, Sch Med, Dept Pathol, Harper Univ Hosp, Detroit, MI 48201 USA
[2] Karmanos Canc Inst, Detroit, MI 48201 USA
关键词
maspin; lung cancer; adeno carcinoma; subcellular localization; proliferative rate; p53;
D O I
10.1016/j.lungcan.2005.07.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Maspin, a mammary homologue of Serine Protease Inhibitors, has been shown to inhibit tumor progression and metastasis. Recently, its biological functions have been linked to its subcellular localization. Specifically, a nuclear, opposed to a combined nuclear and cytoplasmic localization has been associated with increased survival in human malignancies, including non-small cell lung cancer (NSCLC). However, it is not known whether transformation affects maspin expression during lung carcinogenesis, and whether its subcellular localization correlates with the morphological features of NSCLC. To address these questions, we studied maspin expression in a model of transformation of bronchial epithelial cells and in resected NSCLC. We found that decreased maspin accompanied chemical transformation of normal immortalized bronchial epithelial cells BEAS 2B. Immunohistochemistry revealed maspin expression to be virtually universal in NSCLC, occurring in 72/77 Adenocarcinoma (ACa), and 46/46 squamous cell carcinoma (SqCCa). SqCCa showed almost exclusively a combined nuclear-cytosotic stain. In contrast, nuclear maspin, but not combined nuclear-cytoplasmic maspin significantly correlated with low histological grade, tower proliferative rate, absence of invasion, and negative p53 stain in ACa. These data support the hypothesis that nuclear localization of maspin may stratify subtypes of NSCLC with favorable clinical-pathological features. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:31 / 39
页数:9
相关论文
共 53 条
[1]   Maspin functions as a tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells [J].
Abraham, S ;
Zhang, WG ;
Greenberg, N ;
Zhang, M .
JOURNAL OF UROLOGY, 2003, 169 (03) :1157-1161
[2]   Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses [J].
Bhattacharjee, A ;
Richards, WG ;
Staunton, J ;
Li, C ;
Monti, S ;
Vasa, P ;
Ladd, C ;
Beheshti, J ;
Bueno, R ;
Gillette, M ;
Loda, M ;
Weber, G ;
Mark, EJ ;
Lander, ES ;
Wong, W ;
Johnson, BE ;
Golub, TR ;
Sugarbaker, DJ ;
Meyerson, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13790-13795
[3]   Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas [J].
Bièche, I ;
Girault, I ;
Sabourin, JC ;
Tozlu, S ;
Driouch, K ;
Vidaud, M ;
Lidereau, R .
BRITISH JOURNAL OF CANCER, 2003, 88 (06) :863-870
[4]  
Biliran H, 2001, CANCER RES, V61, P8676
[5]   Ultrastructural and molecular heterogeneity in non-small cell lung carcinomas:: Study of 110 cases and review of the literature [J].
Bombi, JA ;
Martínez, A ;
Ramírez, J ;
Grau, JJ ;
Nadal, A ;
Fernández, PL ;
Palacín, A ;
Cardesa, A .
ULTRASTRUCTURAL PATHOLOGY, 2002, 26 (04) :211-218
[6]   MONOCLONAL-ANTIBODIES AGAINST RECOMBINANT PARTS OF THE KI-67 ANTIGEN (MIB-1 AND MIB-3) DETECT PROLIFERATING CELLS IN MICROWAVE-PROCESSED FORMALIN-FIXED PARAFFIN SECTIONS [J].
CATTORETTI, G ;
BECKER, MHG ;
KEY, G ;
DUCHROW, M ;
SCHLUTER, C ;
GALLE, J ;
GERDES, J .
JOURNAL OF PATHOLOGY, 1992, 168 (04) :357-363
[7]   Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis [J].
Cher, ML ;
Biliran, HR ;
Bhagat, S ;
Meng, YH ;
Che, MX ;
Lockett, J ;
Abrams, J ;
Fridman, R ;
Zachareas, M ;
Sheng, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7847-7852
[8]  
Czerwenka KF, 2001, CANCER DETECT PREV, V25, P268
[9]   Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas [J].
Dobashi, Y ;
Jiang, SX ;
Shoji, M ;
Morinaga, S ;
Kameya, T .
JOURNAL OF PATHOLOGY, 2003, 199 (02) :208-220
[10]  
Gandara DR, 2001, LUNG CANCER, V34, pS75